Glyxambi

Empagliflozin,

Linagliptin

5.4 Moderate risk

Glyxambi & Diabetic ketoacidosis

12.6%

of users reported Diabetic ketoacidosis

60.5%

also reported Hospitalization

62.7%

are women

Most common medical consequences

Hospitalization
60.5%
Severe reaction
37.0%
Life-threatening condition
2.5%

Have you experienced any negative side effects from this medication?

Glyxambi: general information

Most common side effects (27)

Most commonly affected ages

40 - 49 years
16.6%
50 - 59 years
30.9%
60 - 69 years
36.9%
70 - 79 years
15.6%